Prognosis of chronic hepatitis C: Results of a large, prospective Cohort study

Hepatology

Volumn 28, Issue 6, 1998, Pages 1687-1695

  Niederau, Claus ^a,d   Lange, Stefan ^b   Heiniges, Tobias ^a   Erhardt, Andreas ^a   Buschkamp, Marlies ^a   Hürter, Dietmar ^a   Nawrocki, Marek ^a   Kruska, Lothar ^c   Hensel, Frank ^a   Petry, Wolfgang ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Dr Stein Laboratory   (Germany)

^d St Josef Hospital Oberhausen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA INTERFERON;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BILIRUBIN BLOOD LEVEL; DISEASE DURATION; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ABUSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 17344370538     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280632     Document Type: Article

References (27)

1. Mattson L, Weiland O, Glaumann H. Long-term follow-up of chronic posttransfusion non-A, non-B hepatitis: clinical and histological outcome. Liver 1988;8:184-188.
2. Realdi G, Alberti A, Rugge M, et al. Long-term follow-up of acute and chronic posttransfusion non-A, non-B hepatitis: evidence of progression to liver cirrhosis. Gut 1982;23:270-275.
3. DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
4. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
5. Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis: looking back in the second decade. Ann Intern Med 1993;119:110-115.
6. Crowe J, Doyle C, Fielding JF, et al. Presentation of hepatitis C in a uniform cohort 17 years from inoculation. Gastroenterology 1995;108:A1054.
7. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural history of chronic hepatitis. Am J Gastroenterol 1993;88:240-243.
8. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated globulin. N Engl J Med 1994;331:1607-1611.
9. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcome after transfusion-associated hepatitis. N Engl J Med 1995;332:1463-1466.
10. Tremolda F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, Realdi G. Long-term follow-up on non-A, non-B hepatitis posttransfusion hepatitis. J Hepatol 1992;16:273-281.
11. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. HEPATOLOGY 1996;23:1334-1340.
12. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
13. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-472.
14. Fattovich G, Giustina G, Degos F, et al. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. J Hepatol 1997;27:201-205.
15. Dienstag J. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997;112:652-655.
16. Serfaty L, Poujol A, Chazouilleres O, et al. Risk factors for liver cirrhosis occurrence in patients with chronic HCV infection: a case control study. HEPATOLOGY 1996;24:A151.
17. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH, Collaborative Study Group. Hepatitis C virus genotypes in the United states: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996;125:634-639.
18. Holtzmuller K, Rholl J, Squire O, Sjogren MH. Does ethnic background, gender, or alcohol have a role in clinical severity of hepatitis C (HCV)? HEPATOLOGY 1996;24:A379.
19. Romeo R, Tommasini MA, Rumi MG, et al. Genotypes in the progression of hepatitis C related cirrhosis and development of hepatocellular carcinoma. HEPATOLOGY 1996;24:A153.
20. Dusheiko G, Weiss HS, Brown D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. HEPATOLOGY 1994;19:13-18.
21. Tanaka E, Kiyosawas K, Matsushima T, et al. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver disease: a multi-institutional analysis. J Gastroenterol Hepatol 1995:10:538-545.
22. Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-168.
23. Pozzato G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, Kaneko S. Severity of liver disease with different hepatitis C viral clones [Letter]. Lancet 1991;338:509.
24. Ichimura H, Tamura I, Kurimura O, Koda T, Mizuki M, Tuchie H, Kurimura T. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease. J Med Virol 1994;43:212-215.
25. Silini E, Bono F, Cividini A, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995;21:285-290.
26. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. HEPATOLOGY 1996;23:695-699.
27. Zein NN, Abdulkarim AS, Brandhagen D, Therneau T, Persing DH. Chronic hepatitis C infection (HCV) in the U.S.: an insight into the natural history and evidence for a change in the epidemiology of HCV genotypes. HEPATOLOGY 1996;24:A150.